
News|Articles|February 13, 2019
Aemcolo for Noninvasive Escheria coli Infection
Author(s)Drew Boxler
Advertisement
Aemcolo (rifamycin, Cosmo Pharmaceuticals)
Indications: treatment of travelers’ diarrhea caused by noninvasive strains of Escherichia coli in adults.
Dosage: Two 388mg tablets taken orally, twice daily for three days.
Contraindications: known hypersensitivity to rifamycin, any of the other rifamycin class antimicrobial agents (e.g. rifaximin), or any of the components in AEMCOLO
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Pharmacists Take Control of Medical Billing
2
Data Show Rise in GLP-1 Poison Center Calls Tied to Dosing Errors
3
Lowered Pneumococcal Vaccination Age Has Yet to Close Awareness Gap
4
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol
5






























